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Abstract
Background: β-lactams target the peptidoglycan layer in the bacterial cell wall and most β-lactam antibiotics cause
filamentation in susceptible Gram-negative bacteria at low concentrations. The objective was to determine the initial
morphological response of cephalosporin resistant CTX-M-1-producing E. coli to cefotaxime and to determine whether
the response depended on the growth phase of the bacterium and the concentration of antibiotic.
Results: Two antibiotic resistant strains carrying blaCTX-M-1 on the chromosome and on an IncI1 plasmid and three
sensitive strains were used in this study. The resistant strains displayed elongated cells when exposed to cefotaxime at
sub-inhibitory as well as therapeutic concentrations (1 to 512 mg/L of cefotaxime) in both lag and early exponential phase,
suggesting that the elongation was an initial response mechanism to the antibiotic. Normal sized cells were the dominant
cell type in exponential and stationary growth phase. No elongated cells were seen in cultures without cefotaxime. In
cultures with high concentrations of cefotaxime (128–512 mg/L), no growth other than initial filamentation was observed,
but spheroplats appeared after 14–17 hours in cultures of the resistant strains. Filaments were also observed in sensitive
control strains with sub-inhibitory concentrations of cefotaxime.
Conclusions: We showed that E. coli resistant to β-lactams by an extended-spectrum β-lactamase, blaCTX-M-1, produced
filaments when exposed to cefotaxime. The filament formation was restricted to early growth phases and the time the
cells grew as filaments was antibiotic concentration dependent. This indicates that antibiotic resistant E. coli undergo
the same morphological changes as sensitive bacteria in the presence of β-lactam antibiotic. It was showed that the
filament formation was an initial response to the antibiotics.
Keywords: Antimicrobial resistance, CTX-M-1, Filaments
Background
β-lactams are bactericidal antibiotics that target the pep-
tidoglycan layer in the bacterial cell wall by covalently bind-
ing to the penicillin-binding proteins. This inhibits the last
stage of peptidoglycan synthesis, namely the crosslinking
formation [1,2]. Gram-negative bacteria generally respond
to β-lactam antibiotics by either (a) rapid cell lysis, (b) the
production of cell-wall-deficient round cells or (c) filament
formation [3]. Most β-lactam antibiotics cause filamenta-
tion in susceptible Gram-negative bacteria at low concen-
trations [3,4]. These morphology changes often depend
on the antibiotic concentration and the binding site
specifications [3,5]. Greenwood et al. found that cephalo-
sporins, such as cefotaxime, induce filament production
from susceptible Escherichia coli up to a concentration of
2 mg/L [6]. However, only limited knowledge is available
about morphology changes in β-lactam resistant bacteria
treated with β-lactams. Demirel et al. recently found that
extended spectrum β-lactamase producing uropathogenic
E. coli changed their morphology into filamentous forms
when treated with ceftibuten [7]. However, the bacteria did
not change morphology when treated with trimethoprim or
ciprofloxacin.
In this study, we investigated the morphology changes
of extended spectrum β-lactamase-producing E. coli (car-
rying blaCTX-M-1) exposed to cefotaxime at sub-inhibitory
and therapeutic concentrations. The objectives of this
study were i) to determine if an antibiotic resistant CTX-
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M-1-producing E. coli exposed to cefotaxime at sub-
inhibitory and therapeutic concentrations produced fila-
ments, even though the strain is resistant to β-lactams and
ii) to evaluate if the filamentation was growth phase and
antibiotic concentration dependent.
Methods
Bacterial strains
The bacteria used in this study carried blaCTX-M-1 on the
chromosome (MG1655/CTX-M-1 (E. coli K-12 MG1655
ΔYbeM::CTX-M-1 )) and on an IncI1 plasmid (MG1655/
IncI1/CTX-M-1 (E. coli K-12 MG1655 + IncI1/CTX-M-
1)). The strains have previously been described in detail
[8]. Two control strains, MG1655/NCS and MG1655/
IncI1/NCS containing a non-coding sequence (NCS) in
the chromosome and on an IncI1 plasmid, respectively,
with the same length as blaCTX-M-1 were constructed to
control for insertion site and plasmid. The NCS was
cloned into the pseudo gene ybeM [9] of E. coli K-12
MG1655 using the Lambda Red recombination system as
described previously [10-12]. Plasmid p2795 was used to
construct template vectors. Sequences of oligonucleotides
used for Lambda Red mediated mutagenesis and PCR
verifications were: NCS-ybeM-F: 5′- ATGCTGGTGGCA
CTTCAGGCAGGAAACATCGTCGCCCGTAATTACG
CATGATTATAATGCGTCAGCC-3′, NCS-ybeM-R: 5′-A
GGCGGCAGGAAGTACCAGGATTTCAGCTCCCTGT
AATCGTGTAGGCTGGAGCTGCTTC-3′, NCS-IncI1-F:
5′-CACACGTGGAATTTAGGTTAGACTATAAATAG
AAAAATTACGCATGATTATAATGCGTCAGCC-3′, In
cI1-R: 5′-TCTAAGGCGATAAACAAAAACGGAATGA
GTTTCCCCATTCGTGTAGGCTGGAGCTGCTTC-3′,
NCS-F: 5′-GATTATAATGCGTCAGCCCGTGTAGG-3′
and NCS-R: 5′-GATAGTAGTCCGCCCATTCGAACGG-
3′. Insertions were confirmed by PCR and sequencing using
standard procedures. Strains were maintained in Difco™ Ly-
sogeny broth (LB), Lennox (Becton, Dickinson and Com-
pany, Albertslund, Denmark) and on LB agar plates (Becton,
Dickinson and Company, Albertslund, Denmark). During
strain construction the medium was supplemented with
kanamycin (30 mg/L) (Sigma, Copenhagen, Denmark) when
appropriate.
Growth conditions
Bacterial morphology was investigated by performing
growth experiments on an oCelloScope (Unisensor,
Alleroed, Denmark) for 24 hours at 37°C (no shaking).
Cultures were prepared in aliquots of 100 μL Mueller
Hinton II (MH-2) broth (Sigma, Copenhagen, Denmark)
supplemented with 0 to 512 mg/L of cefotaxime (in two-
fold dilutions) (Sigma, Copenhagen, Denmark) for the
resistant strains and supplemented with 0 to 4 mg/L of
cefotaxime (in two-fold dilutions) for the sensitive strains.
The cultures were inoculated with 1–5 single colonies
from a blood agar plate (blood agar base (Oxoid, Roskilde,
Denmark) supplemented with 5% blood from cattle) to a
final cell density of 106 cfu/mL, using a Sensititre™ Neph-
elometer (Thermo Scientific™, Roskilde, Denmark) with a
McFarland 0.5 standard (1–2 x 108 cfu/mL). Cefotaxime
was added to the media just before inoculation with cells
from blood plates. Images of the cultures were acquired
with 10-minute intervals through the oCelloScope bright
field camera (magnification of approximately 200× and
resolution of 1.3 μm). The growth of the cultures was also
measured by the oCelloScope using a background cor-
rected absorption algorithm (BCA, former called pixel
histogram summation (PHS)) [13]. For more detailed pic-
tures culture material was investigated in a Zeiss micro-
scope with a ph3 Plan-neoflur 100x/1.30 oli, ∞/1.7 lens
with a Zeiss AxioCam camera.
Antimicrobial susceptibility testing
The MIC of cefotaxime was determined using the broth
microdilution method following the CLSI guidelines
[14], as described previously [8].
Results
The MIC of cefotaxime for the two isogenic β-lactam re-
sistant strains, MG1655/CTX-M-1 carrying blaCTX-M-1
on the chromosome and MG1655/IncI1/CTX-M-1 car-
rying blaCTX-M-1 on an IncI1 plasmid have been deter-
mined in a previous study and were 168 mg/L ± 4 mg/L
and 252 mg/L ± 4 mg/L, respectively [8]. The MICs of
cefotaxime were 0.032 mg/L, 0.032 mg/L and 0.064 mg/
L for the three sensitive control strains E. coli K-12
MG1655, MG1655/NCS, and MG1655/IncI1/NCS,
respectively.
Normal sized growing cells were observed in the cul-
tures of cefotaxime-resistant MG1655/CTX-M-1 and
MG1655/IncI1/CTX-M-1 when grown without cefotax-
ime (Figure 1A-1, 6). However, filaments were observed
in all cultures with 1 mg/L to 512 mg/L of cefotaxime
already in the lag and early exponential growth phase
(Figure 1A-2, 4, 5, 7, 8, 9, 10 and Figure 2), and the fila-
ments remained the predominant cell format, and right
after onset to exponential phase (here defined according
to growth measured on an oCelloScope by BCA; lag
phase: approx. 0–0.1, early exponential phase: approx.
0.1-0.4, exponential phase: approx. 0.4-2.2 and station-
ary phase: approx. 2.2-2.5). In cultures of the resistant
strains with concentrations of cefotaxime below the
MIC, normal sized cells started to be seen together with
elongated cells when the culture entered exponential
phase (Figure 1B), and in exponential growth phase, this
cell type was the dominant one (BCA approx. 0.6). The
filaments were up to 16 times longer than normal sized
cells (Figure 2). In cultures with cefotaxime at or above
the MIC of the two resistant strains, elongated cells
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formed and were present 2 hours after inoculation even
though no further growth was seen in the culture
(Figure 1B). In these cultures, spheroplats were ob-
served after 14–17 hours (Figure 1A-5, 10).
Filaments were not observed in the sensitive strains
when grown without cefotaxime (Figure 1A-11, 13).
When sub-inhibitory concentrations of cefotaxime were
present, filaments were observed 2 hours after inoculation
(Figure 1A-12, 14). In contrast to the resistant strains,
growth continued in filament networks (Figure 1B). No
growth was seen above 0.016 mg/L cefotaxime for MG1655
and MG1655/NCS and above 0.032 mg/L cefotaxime for
MG1655/IncI1/NCS. In cultures with cefotaxime at or
above the MIC of the strains, elongated cells were present
(See figure on previous page.)
Figure 1 Cell morphology of MG1655/CTX-M-1, MG1655/IncI1/CTX-M-1, MG1655/NCS and MG1655/IncI1/NCS cultured with and
without cefotaxime. (A) Filmentation at different cefotaxime concentrations. Pictures are taken in early exponential phase, except where stated
otherwise. (1–5) MG1655/CTX-M-1 cultured without cefotaxime, with 4 mg/L cefotaxime, with 16 mg/L cefotaxime, with 32 mg/L cefotaxime
and with 256 mg/L cefotaxime, respectively. (6–10) MG1655/IncI1/CTX-M-1 cultured without cefotaxime, with 4 mg/L cefotaxime, with 16 mg/L
cefotaxime, with 64 mg/L cefotaxime and with 256 mg/L cefotaxime, respectively. Picture (5) and (10) were taken in late stationary phase. (11–12)
MG1655/NCS cultured without cefotaxime and with 0.016 mg/L cefotaxime, respectively. (13–14) MG1655/IncI1/NCS cultured without cefotaxime
and with 0.032 mg/L cefotaxime, respectively. (B) Filamentation and growth phase dependency. The growth curves are representative drawings,
where the morphology of the cells (resistant or sensitive) is marked at different growth phases. The strains were grown in MH-2 broth with and
without cefotaxime on an oCelloScope.
Figure 2 Cell morphology of MG1655/CTX-M-1 and MG1655/IncI1/CTX-M-1 cultured with and without cefotaxime. Pictures are taken in
early exponential phase. (A) MG1655/IncI1/CTX-M-1 cultured without cefotaxime, (B) MG1655/CTX-M-1 cultured with 32 mg/L cefotaxime, (C)
MG1655/CTX-M-1 cultured with 2 mg/L cefotaxime and (D) MG1655/IncI1/CTX-M-1 cultured with 16 mg/L cefotaxime. MG1655/CTX-M-1 and
MG1655/IncI1/CTX-M-1 were grown in MH-2 broth with and without cefotaxime and pictures were taken with a Zeiss microscope.
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2 hours after inoculation even though no further growth
was seen in the cultures (Figure 1B). Spheroplats were not
seen in the cultures with the sensitive cells.
Discussion
In this study we investigated the morphology changes of
CTX-M-1-producing E. coli exposed to cefotaxime at sub-
MIC, MIC and above MIC concentrations. Paulander
et al. have previously demonstrated filamentation of wild-
type E. coli MG1655 cells when exposed to ampicillin
(5 g/L) and norfloxacin (250 ng/mL and 2500 ng/mL),
when the cultures reached a cell density of 108 cells/ml
[15]. This corresponds well to the morphological response
observed in the present study for cefotaxime-sensitive E.
coli MG1655 cells, where filament formation was found to
be the response to cefotaxime at both sub-MIC and MIC
concentrations. Other studies also demonstrated that fila-
ment production occurs in sensitive Gram-negative strains
[3,4]. In the current study we showed that E. coli resistant
to β-lactams by an extended-spectrum β-lactamase,
blaCTX-M-1, also produced filaments when exposed to cef-
otaxime. In a recent study performed by Demirel et al. it
was shown that CTX-M-15-producing uropathogenic E.
coli changed its morphology into filamentous forms when
treated with ceftibuten [7]. These observations are in cor-
relation with the ones observed in this study. The filament
formation in this current study was observed as an initial
growth response, irrespective of the antibiotic concentra-
tion, and filaments were observed in both lag and early
logarithmic phase. When the cultures grew in the logarith-
mic phase normal size cell started to become dominant.
Hence, the filamentation was restricted to certain growth
phases and happened as an initial response to the cefotax-
ime treatment. Filamentation has been suggested to be in-
volved in bacterial survival during antimicrobial therapies
[16]. Hence, filamentation could be an intended response
of the bacteria when it is stressed and threatened to be
killed by antibiotics [16].
In the sensitive strains cultured with sub-MIC concen-
trations of cefotaxime, the growth continued in a filament
network manner throughout the whole growth cycle, after
the filaments were observed approximately 2 hours after
the inoculation. Cefotaxime is active in the periplasm of E.
coli, where it gets hydrolysed by the CTX-M-1 β-lactamase
in the resistant strains. According to EcoCyc more than 35
cell division proteins exists. A study by Spartt showed that
β-lactams that specifically inhibit cell division, bind prefer-
entially to penicillin binding protein 3 (PBP3/ftsI) [17]. Cef-
otaxime shows high affinity for PBP3, which is required for
septum formation. Studies have shown that when PBP3 is
inhibited, the cells produce filaments [18,19]. Previous
studies also showed that sulA (sfiA) and capR are involved
in the filamentation of E. coli [20,21]. Furthermore, Miller
et al. showed that the SOS-promoting recA, lexA and dpiA
are involved in inhibiting cell division [22]. It is speculated
that initially cefotaxime binds to PBP3 in the resistant
strains, which induce the production of filaments. How-
ever, when CTX-M-1 was produced in high enough quan-
tities in the resistant cells, cefotaxime was hydrolysed and
not able to bind to PBP3 anymore. The cells then initiate
growth with normal sized cells. In a previous study of ours
it was shown that the CTX-M-1 protein levels increased 2
fold or more from lag to logarithmic phase [8], which sug-
gests that it is not until logarithmic phase that high enough
CTX-M-1 concentrations are present to degrade the drug.
Furthermore, the time the cells grew as filament forms was
antibiotic concentration dependent (longer lag phase with
higher concentrations of drug [8]), which corresponds
nicely with that it would take longer time for the CTX-M-
1 enzyme to hydrolyse the drug “completely”, the higher
the cefotaxime concentration, thus, prolonging the time
before growth with normal sized cells can initiate. As the
sensitive cells are not able to hydrolyse cefotaxime at all,
they grow in filament forms in the entire growth cycle
when sub-MIC concentrations of cefotaxime were present.
As mentioned, filaments were observed with all cefotax-
ime concentrations tested, which suggest that the filamen-
tation formation per se was not concentration dependent.
Elongated cells were developed and observed 2 hours after
inoculation in cultures even with cefotaxime concentra-
tions at or above the MIC. No further growth was ob-
served in these cultures; however, the resistance strains
did also not undergo further morphological changes for
14–17 hours and the sensitive cells did not undergo fur-
ther morphological changes at all in the time investigated.
This is very interesting as cefotaxime is a bactericidal drug,
and more investigations are needed to fully understand
this phenomenon and to demonstrate whether such cells
have the ability to re-enter into a growing stage. Finally
after 14–17 hours, spheroplats which are osmotically fra-
gile cells [5] were observed in the cultures of the resistance
strains at or above MIC. That fact that filaments were ob-
served in the first 2 hours after inoculation at all cefotax-
ime concentrations, even those at or above MIC, suggests
that it takes approximately 2–3 hours before the cefotax-
ime concentrations in the periplasm is high enough to
fully be active. It has been shown that cefotaxime has a ra-
ther slow bacterial diffusion rate through porin-channels
of E. coli K-12 [23], which may be a contributing factor to
this observation.
Conclusions
These results show that resistant E. coli undergoes the
same morphological changes as sensitive E. coli in the
presence of β-lactam antibiotic in the lag and initial loga-
rithmic phase. However, when the β-lactams had been de-
graded to a critical concentration, the cells initiate growth
with normal sized cells, in contrast to the sensitive strains,
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which continued growth in a filament network manner.
The results suggest that the filamentation is an initial re-
sponse to the cefotaxime treatment regardless of whether
the bacteria are resistant or not.
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